BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang XM, Zhong X, Du YJ, Guo YY, Pan TR. Effects of glucagon-like peptide-1 receptor agonists on glucose excursion and inflammation in overweight or obese type 2 diabetic patients. World J Diabetes 2023; 14(8): 1280-1288 [PMID: 37664475 DOI: 10.4239/wjd.v14.i8.1280]
URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1280.htm
Number Citing Articles
1
Tirzepatide a novel anti diabetic molecule unfold dual actionDiscover Public Health 2024; 21(1) doi: 10.1186/s12982-024-00200-2
2
Е. L. Nasonov, Т. S. Panevin, Е. А. Troshina. Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatologyRheumatology Science and Practice 2024; 62(2): 135 doi: 10.47360/1995-4484-2024-135-144
3
Fan Yang, Lenian Zhou, Jieyuan Zhang, Qiuke Wang, Qianying Cai, Jiazheng Wang, Chenglin Wu, Xueqian Li, Jinshan Zhang, Yongqiang Zheng, Xin Ma, Hongyi Zhu, Zhongmin Shi. Association of semaglutide use with outcomes in chronic plantar heel pain: a prospective observational cohort and a pilot interventional studyInternational Journal of Surgery 2025; 111(12): 9333 doi: 10.1097/JS9.0000000000003156